| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |